IP Library Granted Patent US 10,669,063
Granted Patent B2
US 10,669,063 · App. 15/604,429 · Granted Jun 2, 2020

System for compounding and packaging ready to reconstitute drug powders of solutions to a solution or to a suspension or to an injectable

Inventors: William Stratis (Brooklyn, NY); Serafin Gonzalez (Miami, FL)
Assignee: ARCHON PHARMACEUTICAL CONSULTING LLC
B65D17/06A61F9/0008A61J1/1418A61J1/1481A61J1/067A61J1/20A61J1/2075A61J1/2089A61J1/2096B65D47/18Y10S215/08Y10S604/905
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,669,063
App. No.
15/604,429
Granted
Jun 2, 2020
Kind
B2
Abstract

A system and method for mixing compounds is disclosed. Accordingly to one embodiment a transfer device is provided that allows for diluent from a syringe to be introduced into a container having a first compound (e.g., powder) in a sterile manner. In second and third embodiments, systems are shown for combining and mixing first and second compounds contained in first and second containers in a sterile manner. Various dropper tips for dispensing the mixed compounds are disclosed.

Claims (22)

1. A system for sterilely mixing compounds to provide an ophthalmic compound and configured to directly administer the mixed compounds from a mixing vessel to an eye of a patient, comprising:

a first container for containing a first compound, the first container having a collar defining an opening;

a second container for containing a second compound, the second container having a collar defining an opening;

a first membrane disposed over the opening of the first container, wherein the first membrane is capable of being punctured in order to provide fluid communication to an interior of the first container;

a second membrane disposed over the opening of the second container, wherein the second membrane is capable of being punctured in order to provide fluid communication to an interior of the second container;

a sleeve sized and shaped to removably engage the collars of the first and second containers; and

a puncture member extending on first and second sides of the sleeve, the puncture member sized and shaped to puncture the first and second membranes in a first condition in which the sleeve is engaged with the collars of the first and second containers, the puncture member defining a first fluid communication passage that permits fluid from one of the containers into the other, the puncture member defining a second communication passage that permits fluid flow of in the opposite direction as the first passage in order to provide equalization of pressure between the first and second containers;

a vent member that provides a fluid communication passage through a wall of the sleeve such that when the sleeve is in a first condition and engaged with the collars of the first and second containers, air can be expelled from at least one of the first and second containers the through the vent as fluid is introduced into the first container wherein the length of the vent is smaller than the diameter of the sleeve;

a dropper tip that is sized and shaped to removably engage the collar having a complementary structure to the sleeve such that the dropper tip can be attached to the first container with the sleeve removed from the first container, the dropper tip having a static open lumen permitting controlled dispensing of a mixture of the first compound and a fluid that has been previously introduced; and

a drain port disposed on an underside if the dropper tip, the drain port being sized and shaped to pass through the membrane and provides a fluid communication passage through the drain port to a dispensing end of the dropper tip,

wherein the first container is at least partially deformable to facilitate dispensing the mixture of the first compound and the fluid upon squeezing and the dropper tip is sized and shaped to dispense a sterilely mixed medication directly from the first container to the patient eye.

2. The system of claim 1 , further comprising:

first and second protective caps sized and shaped to be removably disposed over the first and second membranes, the protective caps providing additional protection against inadvertent puncture of the membranes and being removable prior to engagement of the sleeve with the collars.

3. The system of claim 1 , wherein the collars and the sleeve include threads that permit the removable engagement of the respective threaded portions of the collars and sleeve.

4. The system of claim 1 , wherein the vent includes a one-way valve that permits air in at least one of the first and second containers to be expelled and does not permit air, microbes and a combination thereof to enter either of the first and second containers from the outside environment.

5. The system of claim 1 , wherein the first compound is a powder drug and the second compound is a diluting fluid.

6. The system of claim 1 , wherein the first compound is ceftazidime.

7. The system of claim 1 , wherein the first compound is vancomycin.

8. The system of claim 1 , wherein the dropper tip includes a filter to prevent outflow of at least one of microbes, contaminants, unmixed drug and a combination thereof from the first container into a patient eye.

9. The system of claim 8 , wherein the filter is a 5 micron filter.

10. The system of claim 1 , wherein the dropper tip can be used to directly administer a mixed solution to a patient.

11. The system of claim 1 , wherein at least a portion of the first container is translucent such that contents of the first container can be viewed through the translucent portion.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE TO REMOVE THE SECOND ASSIGNEE, CHANGE THE CONVEYANCE TYPE PREVIOUSLY RECORDED ON REEL 72628 FRAME 950. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Feb 27, 2026
From: ARCHON PHARMACEUTICAL CONSULTING (APC) LLC
To: STRATIS, WILLIAM A, DR.
Reel/Frame 075046/0607 →
CHANGE OF NAME Recorded Oct 21, 2025
From: ARCHON PHARMACEUTICAL CONSULTING (APC) LLC
To: STRATIS, WILLIAM A, DR.; GONZALEZ, SERAFIN, DR.
Reel/Frame 072628/0950 →
Continuity (5)
Division 14357728
Provisional Application 61792792 · Mar 15, 2013
Provisional Application 61738535 · Dec 18, 2012
Provisional Application 61684467 · Aug 17, 2012
Related Publication 20170253372A1 · Sep 7, 2017
Cited By (1)
US 12,258,200